http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PH-12015502667-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3166d2820b5872ab84d235e5fae1d45
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-325
filingDate 2015-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08dcea3123f1fe7ff64fbb84bd3675df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f83e7e56cbd68ef76f87e7fc18a90487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed09f7e4c141cda5d0ecdd086c4827e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99af6edbe58a47ef99be96a96c070528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00c678bab497fb0a1d4ad29304bfa638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d0c8d969a7ca40b6e7892d22d4d3bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68169b92cd82240ddf7dd30abe5e1d8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fce5671bf0882f6cbb6ee0bf48802709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb94815672c163146e697dbcf0fa247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bede77c0a26a0c5f77a5fe154b7b9a09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a25fb2345b4c31e38b07aaf05c5233b4
publicationDate 2016-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PH-12015502667-A1
titleOfInvention A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities
abstract The present invention provides pyrroles having hypolipidemic hypocholesteremic activities. The invention provides saroglitazar and its pharmaceutically acceptable salts, hydrates, solvates, polymorphs or intermediates thereof. The invention also provides a process for the preparation of saroglitazar. The invention further provides intermediates as well process for preparation thereof.
priorityDate 2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421412119
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60151560

Total number of triples: 29.